AKIN GUMP STRAUSS HAUER & FELD

Lobbying for UCB, INC. · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate · $80,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Trade (domestic/foreign)

Issues related to global biopharmaceutical supply chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem